摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Ethyl 1-(1-methylpiperidin-4-yl)piperidine-4-carboxylate

中文名称
——
中文别名
——
英文名称
Ethyl 1-(1-methylpiperidin-4-yl)piperidine-4-carboxylate
英文别名
——
Ethyl 1-(1-methylpiperidin-4-yl)piperidine-4-carboxylate化学式
CAS
——
化学式
C14H26N2O2
mdl
——
分子量
254.37
InChiKey
GYRNYRHEGWCFOK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.6
  • 重原子数:
    18
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.93
  • 拓扑面积:
    32.8
  • 氢给体数:
    0
  • 氢受体数:
    4

文献信息

  • Thienopyrimidines and Thiazolopyrimidines for Use in Medicine
    申请人:Bower Fairfield Justin
    公开号:US20070244133A1
    公开(公告)日:2007-10-18
    The use of a compound of formula (I) or a pharmaceutically acceptable salt or solvate thereof, wherein X 1 , X 2 , X 3 , X 4 , R a , p, R 1 , Z, Y, R 2 , R 3 and R 4 are as defined in the specification, in the preparation of a medicament for the treatment of C—C chemokine mediated conditions, such as inflammatory disease. Certain compounds of formula (I) are novel and these, together with their preparation are also described and claimed.
    使用公式(I)或其药学上可接受的盐或溶剂,其中X1,X2,X3,X4,Ra,p,R1,Z,Y,R2,R3和R4如规范所定义,在制备治疗C-C趋化因子介导疾病(如炎症性疾病)的药物中使用。公式(I)的某些化合物是新颖的,这些化合物以及它们的制备也被描述和声明。
  • SELECTED CGRP ANTAGONISTS, PROCESSES FOR PREPARING THEM AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS
    申请人:MUELLER Stephan Georg
    公开号:US20110034444A1
    公开(公告)日:2011-02-10
    The present invention relates to the CGRP antagonists of general formula I wherein R 1 , R 2 , R 3 and R 4 are as defined in claim 1 , the tautomers, the isomers, the diastereomers, the enantiomers, the hydrates thereof, the mixtures thereof and the salts thereof and the hydrates of the salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids or bases, as well as those compounds of general formula I wherein one or more hydrogen atoms are replaced by deuterium, pharmaceutical compositions containing these compounds, their use and processes for preparing them.
    本发明涉及通式I的CGRP拮抗剂,其中R1、R2、R3和R4如权利要求1所定义,其互变异构体、异构体、对映异构体、单纯对映体、其水合物、其混合物及其盐和其盐的水合物,特别是其与无机或有机酸或碱的生理可接受的盐,以及其中一个或多个氢原子被氘取代的通式I的化合物,包含这些化合物的药物组合物,它们的用途和制备它们的过程。
  • US7897603B2
    申请人:——
    公开号:US7897603B2
    公开(公告)日:2011-03-01
查看更多